Logo image of LILAK

LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

NASDAQ:LILAK - Nasdaq - BMG9001E1286 - Common Stock - Currency: USD

6.53  -0.16 (-2.39%)

After market: 6.53 0 (0%)

Fundamental Rating

3

Overall LILAK gets a fundamental rating of 3 out of 10. We evaluated LILAK against 32 industry peers in the Diversified Telecommunication Services industry. LILAK has a bad profitability rating. Also its financial health evaluation is rather negative. LILAK has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

LILAK had negative earnings in the past year.
In the past year LILAK had a positive cash flow from operations.
LILAK had negative earnings in each of the past 5 years.
Each year in the past 5 years LILAK had a positive operating cash flow.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -6.29%, LILAK is doing worse than 90.63% of the companies in the same industry.
The Return On Equity of LILAK (-77.60%) is worse than 87.50% of its industry peers.
LILAK's Return On Invested Capital of 4.33% is in line compared to the rest of the industry. LILAK outperforms 59.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LILAK is below the industry average of 7.13%.
The last Return On Invested Capital (4.33%) for LILAK is above the 3 year average (4.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.29%
ROE -77.6%
ROIC 4.33%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

LILAK has a Operating Margin of 13.19%. This is comparable to the rest of the industry: LILAK outperforms 59.38% of its industry peers.
In the last couple of years the Operating Margin of LILAK has declined.
LILAK has a Gross Margin of 77.89%. This is amongst the best in the industry. LILAK outperforms 93.75% of its industry peers.
In the last couple of years the Gross Margin of LILAK has remained more or less at the same level.
Industry RankSector Rank
OM 13.19%
PM (TTM) N/A
GM 77.89%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LILAK is destroying value.
The number of shares outstanding for LILAK has been reduced compared to 1 year ago.
Compared to 5 years ago, LILAK has more shares outstanding
LILAK has a worse debt/assets ratio than last year.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

LILAK has an Altman-Z score of 0.17. This is a bad value and indicates that LILAK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.17, LILAK is doing worse than 71.88% of the companies in the same industry.
The Debt to FCF ratio of LILAK is 35.50, which is on the high side as it means it would take LILAK, 35.50 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 35.50, LILAK is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
A Debt/Equity ratio of 7.47 is on the high side and indicates that LILAK has dependencies on debt financing.
With a Debt to Equity ratio value of 7.47, LILAK is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 7.47
Debt/FCF 35.5
Altman-Z 0.17
ROIC/WACC0.6
WACC7.21%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.08 indicates that LILAK should not have too much problems paying its short term obligations.
The Current ratio of LILAK (1.08) is comparable to the rest of the industry.
A Quick Ratio of 1.08 indicates that LILAK should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.08, LILAK perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The earnings per share for LILAK have decreased strongly by -20050.00% in the last year.
The Revenue has decreased by -1.46% in the past year.
LILAK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.88% yearly.
EPS 1Y (TTM)-20050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27524%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-1.45%

3.2 Future

Based on estimates for the next years, LILAK will show a very strong growth in Earnings Per Share. The EPS will grow by 27.00% on average per year.
The Revenue is expected to grow by 2.60% on average over the next years.
EPS Next Y83.43%
EPS Next 2Y45.01%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue Next Year0.04%
Revenue Next 2Y1.57%
Revenue Next 3Y2.36%
Revenue Next 5Y2.6%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
LILAK is valuated rather expensively with a Price/Forward Earnings ratio of 19.02.
62.50% of the companies in the same industry are more expensive than LILAK, based on the Price/Forward Earnings ratio.
LILAK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 19.02
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LILAK indicates a rather cheap valuation: LILAK is cheaper than 84.38% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LILAK is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.67
EV/EBITDA 5.82
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LILAK's earnings are expected to grow with 30.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.01%
EPS Next 3Y30.42%

0

5. Dividend

5.1 Amount

No dividends for LILAK!.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (7/18/2025, 8:00:02 PM)

After market: 6.53 0 (0%)

6.53

-0.16 (-2.39%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-30 2025-07-30
Inst Owners65.32%
Inst Owner Change0.01%
Ins Owners11.61%
Ins Owner ChangeN/A
Market Cap1.31B
Analysts76
Price Target7.84 (20.06%)
Short Float %14.55%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1197.36%
Min EPS beat(2)-1558.43%
Max EPS beat(2)-836.29%
EPS beat(4)0
Avg EPS beat(4)-10460.5%
Min EPS beat(4)-28858.2%
Max EPS beat(4)-836.29%
EPS beat(8)3
Avg EPS beat(8)-5243.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.19%
Revenue beat(12)0
Avg Revenue beat(12)-3.11%
Revenue beat(16)1
Avg Revenue beat(16)-2.37%
PT rev (1m)0.32%
PT rev (3m)-3.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-215.79%
EPS NY rev (1m)-150.38%
EPS NY rev (3m)-516.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.43%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-1.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.02
P/S 0.29
P/FCF 5.67
P/OCF 1.72
P/B 1.28
P/tB N/A
EV/EBITDA 5.82
EPS(TTM)-4.03
EYN/A
EPS(NY)0.34
Fwd EY5.26%
FCF(TTM)1.15
FCFY17.64%
OCF(TTM)3.79
OCFY58.04%
SpS22.22
BVpS5.11
TBVpS-20.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.29%
ROE -77.6%
ROCE 5.48%
ROIC 4.33%
ROICexc 4.58%
ROICexgc 9.41%
OM 13.19%
PM (TTM) N/A
GM 77.89%
FCFM 5.18%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
ROICexc(3y)4.63%
ROICexc(5y)4.26%
ROICexgc(3y)9.72%
ROICexgc(5y)8.98%
ROCE(3y)5.45%
ROCE(5y)5.02%
ROICexcg growth 3Y-0.27%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-1.91%
ROICexc growth 5Y1.9%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 7.47
Debt/FCF 35.5
Debt/EBITDA 4.97
Cap/Depr 55.56%
Cap/Sales 11.88%
Interest Coverage 1.01
Cash Conversion 49.35%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 0.17
F-Score5
WACC7.21%
ROIC/WACC0.6
Cap/Depr(3y)62.1%
Cap/Depr(5y)64.9%
Cap/Sales(3y)12.93%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27524%
EPS Next Y83.43%
EPS Next 2Y45.01%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-1.45%
Revenue Next Year0.04%
Revenue Next 2Y1.57%
Revenue Next 3Y2.36%
Revenue Next 5Y2.6%
EBIT growth 1Y4.36%
EBIT growth 3Y-9.58%
EBIT growth 5Y-1.84%
EBIT Next Year881.92%
EBIT Next 3Y118.96%
EBIT Next 5Y85.12%
FCF growth 1Y15.45%
FCF growth 3Y-8.29%
FCF growth 5Y-8.09%
OCF growth 1Y-6.34%
OCF growth 3Y-9.38%
OCF growth 5Y-3.81%